Skip to main content
Top
Published in: AIDS and Behavior 3/2018

Open Access 01-03-2018 | Original Paper

‘Test and Treat’ Among Women at High Risk for HIV-infection in Kampala, Uganda: Antiretroviral Therapy Initiation and Associated Factors

Authors: Yunia Mayanja, Onesmus Kamacooko, Daniel Bagiire, Gertrude Namale, Pontiano Kaleebu, Janet Seeley

Published in: AIDS and Behavior | Issue 3/2018

Login to get access

Abstract

Data on implementation of ‘Test and Treat’ among key populations in sub-Saharan Africa are still limited. We examined factors associated with prompt antiretroviral therapy/ART (within 1 month of HIV-positive diagnosis or 1 week if pregnant) among 343 women at high risk for HIV infection in Kampala-Uganda, of whom 28% initiated prompt ART. Most (95%) reported paid sex within 3 months prior to enrolment. Multivariable logistic regression was used to determine baseline characteristics associated with prompt ART. Sex work as main job, younger age and being widowed/separated were associated with lower odds of prompt ART; being enrolled after 12 months of implementing the intervention was associated with higher odds of prompt ART. Younger women, widowed/separated and those reporting sex work as their main job need targeted interventions to start ART promptly after testing. Staff supervision and mentoring may need strengthening during the first year of implementing ‘test and treat’ interventions.
Literature
1.
go back to reference Baral S, Beyrer C, Muessig K, et al. Burden of HIV among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(7):538–49.CrossRefPubMed Baral S, Beyrer C, Muessig K, et al. Burden of HIV among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(7):538–49.CrossRefPubMed
2.
3.
go back to reference Kiwanuka N, Ssetaala A, Mpendo J, et al. High HIV-1 prevalence, risk behaviours, and willingness to participate in HIV vaccine trials in fishing communities on Lake Victoria, Uganda. J Int AIDS Soc. 2013;16(1):18621.CrossRefPubMedPubMedCentral Kiwanuka N, Ssetaala A, Mpendo J, et al. High HIV-1 prevalence, risk behaviours, and willingness to participate in HIV vaccine trials in fishing communities on Lake Victoria, Uganda. J Int AIDS Soc. 2013;16(1):18621.CrossRefPubMedPubMedCentral
4.
go back to reference Poteat T, Scheim A, Xavier J, Reisner S, Baral S. Global epidemiology of HIV infection and related syndemics affecting transgender people. J Acquir Immune Defic Syndr. 2016;72(Suppl 3):S210–9.CrossRefPubMedPubMedCentral Poteat T, Scheim A, Xavier J, Reisner S, Baral S. Global epidemiology of HIV infection and related syndemics affecting transgender people. J Acquir Immune Defic Syndr. 2016;72(Suppl 3):S210–9.CrossRefPubMedPubMedCentral
5.
go back to reference Strathdee SA, Stockman JK. Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions. Curr HIV/AIDS Rep. 2010;7:99–106.CrossRefPubMedPubMedCentral Strathdee SA, Stockman JK. Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions. Curr HIV/AIDS Rep. 2010;7:99–106.CrossRefPubMedPubMedCentral
6.
go back to reference Gelmon L. HIV prevention response and modes of transmission analysis. Nairobi: Kenya National AIDS Control Council; 2009. Gelmon L. HIV prevention response and modes of transmission analysis. Nairobi: Kenya National AIDS Control Council; 2009.
7.
go back to reference Joint United Nations Programme on HIV/AIDS. New HIV infections by mode of transmission in West Africa: a multicountry analysis. Geneva: Joint United Nations Programme on HIV/AIDS; 2010. Joint United Nations Programme on HIV/AIDS. New HIV infections by mode of transmission in West Africa: a multicountry analysis. Geneva: Joint United Nations Programme on HIV/AIDS; 2010.
8.
go back to reference Wabwire-Mangen F, Odiit M, Kirungi W, Kaweesa Kisitu D, Wanyama JO. Uganda HIV prevention response and modes of transmission analysis. Kampala: Uganda AIDS Commission; 2009. Wabwire-Mangen F, Odiit M, Kirungi W, Kaweesa Kisitu D, Wanyama JO. Uganda HIV prevention response and modes of transmission analysis. Kampala: Uganda AIDS Commission; 2009.
9.
go back to reference Uganda AIDS Commission. HIV and AIDS Uganda Country progress report; 2013. Kampala: Uganda AIDS Commission; 2014. Uganda AIDS Commission. HIV and AIDS Uganda Country progress report; 2013. Kampala: Uganda AIDS Commission; 2014.
10.
go back to reference Vandepitte J, Bukenya J, Weiss HA, et al. HIV and other sexually transmitted infections in a cohort of women involved in high-risk sexual behavior in Kampala, Uganda. Sex Transm Dis. 2011;38(4):316–23.PubMedPubMedCentral Vandepitte J, Bukenya J, Weiss HA, et al. HIV and other sexually transmitted infections in a cohort of women involved in high-risk sexual behavior in Kampala, Uganda. Sex Transm Dis. 2011;38(4):316–23.PubMedPubMedCentral
11.
12.
go back to reference Sigaloff KC, Lange JM, Montaner J. Global response to HIV: treatment as prevention, or treatment for treatment? Clin Infect Dis. 2014;59(Suppl 1):S7–11.CrossRefPubMedPubMedCentral Sigaloff KC, Lange JM, Montaner J. Global response to HIV: treatment as prevention, or treatment for treatment? Clin Infect Dis. 2014;59(Suppl 1):S7–11.CrossRefPubMedPubMedCentral
14.
go back to reference Uganda Ministry of Health. Addendum to the National Antiretroviral Treatment Guidelines. Kampala: Ministry of Health, Government of the Republic of Uganda; 2013. Uganda Ministry of Health. Addendum to the National Antiretroviral Treatment Guidelines. Kampala: Ministry of Health, Government of the Republic of Uganda; 2013.
15.
go back to reference Lundgren JD, Babiker AG, Gordin F, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795–807.CrossRefPubMed Lundgren JD, Babiker AG, Gordin F, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795–807.CrossRefPubMed
16.
go back to reference World Health Organisation. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV Guidelines. Geneva: World Health Organisation; 2015. World Health Organisation. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV Guidelines. Geneva: World Health Organisation; 2015.
17.
go back to reference Lancet The. HIV: the question is not when to treat, but how to treat. Lancet. 2015;386:1420. Lancet The. HIV: the question is not when to treat, but how to treat. Lancet. 2015;386:1420.
18.
go back to reference World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: WHO; 2016. ISBN 9241549688. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: WHO; 2016. ISBN 9241549688.
19.
go back to reference Boyer S, Iwuji C, Gosset A, et al. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa. AIDS Care. 2016;28(Suppl 3):39.CrossRefPubMedPubMedCentral Boyer S, Iwuji C, Gosset A, et al. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa. AIDS Care. 2016;28(Suppl 3):39.CrossRefPubMedPubMedCentral
20.
go back to reference Charurat ME, Emmanuel B, Akolo C, et al. Uptake of treatment as prevention for HIV and continuum of care among HIV-positive men who have sex with men in Nigeria. J Acquir Immune Defic Syndr. 2015;68(Suppl 2):S114–23.CrossRefPubMedPubMedCentral Charurat ME, Emmanuel B, Akolo C, et al. Uptake of treatment as prevention for HIV and continuum of care among HIV-positive men who have sex with men in Nigeria. J Acquir Immune Defic Syndr. 2015;68(Suppl 2):S114–23.CrossRefPubMedPubMedCentral
21.
go back to reference Hayes R, Floyd S, Schaap A, et al. A universal testing and treatment intervention to improve HIV control: one-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial. PLoS Med. 2017;14(5):e1002292.CrossRefPubMedPubMedCentral Hayes R, Floyd S, Schaap A, et al. A universal testing and treatment intervention to improve HIV control: one-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial. PLoS Med. 2017;14(5):e1002292.CrossRefPubMedPubMedCentral
22.
go back to reference Hsu LC. Truong H-HM, Vittinghoff E, Zhi Q, Scheer S, Schwarcz S. Trends in early initiation of antiretroviral therapy and characteristics of persons with HIV initiating therapy in San Francisco, 2007–2011. J Infect Dis. 2013;209(9):1310–4.CrossRefPubMed Hsu LC. Truong H-HM, Vittinghoff E, Zhi Q, Scheer S, Schwarcz S. Trends in early initiation of antiretroviral therapy and characteristics of persons with HIV initiating therapy in San Francisco, 2007–2011. J Infect Dis. 2013;209(9):1310–4.CrossRefPubMed
23.
24.
go back to reference Liu Y, Ruan Y, Vermund SH, et al. Predictors of antiretroviral therapy initiation: a cross-sectional study among Chinese HIV-infected men who have sex with men. BMC Infect Dis. 2015;15(1):570.CrossRefPubMedPubMedCentral Liu Y, Ruan Y, Vermund SH, et al. Predictors of antiretroviral therapy initiation: a cross-sectional study among Chinese HIV-infected men who have sex with men. BMC Infect Dis. 2015;15(1):570.CrossRefPubMedPubMedCentral
25.
go back to reference Mbonye M, Seeley J, Nalugya R, et al. Test and treat: the early experiences in a clinic serving women at high risk of HIV infection in Kampala. AIDS Care. 2016;28(Suppl 3):33–8.CrossRefPubMed Mbonye M, Seeley J, Nalugya R, et al. Test and treat: the early experiences in a clinic serving women at high risk of HIV infection in Kampala. AIDS Care. 2016;28(Suppl 3):33–8.CrossRefPubMed
26.
go back to reference Knight R, Small W, Thomson K, Gilbert M, Shoveller J. Implementation challenges and opportunities for HIV treatment as prevention (TasP) among young men in Vancouver, Canada: a qualitative study. BMC Public Health. 2016;16:262.CrossRefPubMedPubMedCentral Knight R, Small W, Thomson K, Gilbert M, Shoveller J. Implementation challenges and opportunities for HIV treatment as prevention (TasP) among young men in Vancouver, Canada: a qualitative study. BMC Public Health. 2016;16:262.CrossRefPubMedPubMedCentral
27.
go back to reference De Cock KM. Plus ca change antiretroviral therapy, HIV prevention, and the HIV treatment cascade. Clin Infect Dis. 2014;58(7):1012–4.CrossRefPubMed De Cock KM. Plus ca change antiretroviral therapy, HIV prevention, and the HIV treatment cascade. Clin Infect Dis. 2014;58(7):1012–4.CrossRefPubMed
28.
go back to reference Evans C, Bennett J, Croston M, Brito-Ault N, Bruton J. “In reality, it is complex and difficult”: UK nurses’ perspectives on “treatment as prevention” within HIV care. AIDS Care. 2015;27(6):753–7.CrossRefPubMed Evans C, Bennett J, Croston M, Brito-Ault N, Bruton J. “In reality, it is complex and difficult”: UK nurses’ perspectives on “treatment as prevention” within HIV care. AIDS Care. 2015;27(6):753–7.CrossRefPubMed
29.
go back to reference Karim QA, Dellar RC, Bearnot B, et al. HIV-positive status disclosure in patients in care in Rural South Africa: implications for scaling up treatment and prevention interventions. AIDS Behav. 2015;19(2):322–9.CrossRef Karim QA, Dellar RC, Bearnot B, et al. HIV-positive status disclosure in patients in care in Rural South Africa: implications for scaling up treatment and prevention interventions. AIDS Behav. 2015;19(2):322–9.CrossRef
31.
go back to reference Wilson D, Fraser N. Who pays and why? Costs, effectiveness, and feasibility of HIV treatment as prevention. Clin Infect Dis. 2014;59(suppl 1):S28–31.CrossRefPubMed Wilson D, Fraser N. Who pays and why? Costs, effectiveness, and feasibility of HIV treatment as prevention. Clin Infect Dis. 2014;59(suppl 1):S28–31.CrossRefPubMed
32.
go back to reference Kamali A, Nsubuga R, Ruzagira E, et al. Heterogeneity of HIV incidence: a comparative analysis between fishing communities and in a neighbouring rural general population, Uganda, and implications for HIV control. Sex Transm Infect. 2016;92(6):447.CrossRefPubMedPubMedCentral Kamali A, Nsubuga R, Ruzagira E, et al. Heterogeneity of HIV incidence: a comparative analysis between fishing communities and in a neighbouring rural general population, Uganda, and implications for HIV control. Sex Transm Infect. 2016;92(6):447.CrossRefPubMedPubMedCentral
33.
go back to reference Gregson J, Kaleebu P, Marconi VC, et al. Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study. Lancet Infect Dis. 2017;17(3):296–304.CrossRefPubMed Gregson J, Kaleebu P, Marconi VC, et al. Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study. Lancet Infect Dis. 2017;17(3):296–304.CrossRefPubMed
34.
go back to reference Uganda Ministry of Health. Addendum to the National Antiretorviral Treatment Guidelines. Kampala: Ministry of Health, Government of the Republic of Uganda; 2013. Uganda Ministry of Health. Addendum to the National Antiretorviral Treatment Guidelines. Kampala: Ministry of Health, Government of the Republic of Uganda; 2013.
35.
go back to reference Iwuji CC, Orne-Gliemann J, Larmarange J, et al. Uptake of home-based HIV testing, linkage to care, and community attitudes about ART in Rural KwaZulu-Natal, South Africa: descriptive results from the first phase of the ANRS 12249 TasP cluster-randomised trial. PLoS Med. 2016;13(8):e1002107.CrossRefPubMedPubMedCentral Iwuji CC, Orne-Gliemann J, Larmarange J, et al. Uptake of home-based HIV testing, linkage to care, and community attitudes about ART in Rural KwaZulu-Natal, South Africa: descriptive results from the first phase of the ANRS 12249 TasP cluster-randomised trial. PLoS Med. 2016;13(8):e1002107.CrossRefPubMedPubMedCentral
36.
go back to reference Decker MR, Crago A-L, Chu SK, et al. Human rights violations against sex workers: burden and effect on HIV. Lancet. 2015;385(9963):186–99.CrossRefPubMed Decker MR, Crago A-L, Chu SK, et al. Human rights violations against sex workers: burden and effect on HIV. Lancet. 2015;385(9963):186–99.CrossRefPubMed
37.
go back to reference King EJ, Maman S, Bowling JM, Moracco KE, Dudina V. The influence of stigma and discrimination on female sex workers’ access to HIV services in St. Petersburg, Russia. AIDS Behav. 2013;17(8):2597–603.CrossRefPubMed King EJ, Maman S, Bowling JM, Moracco KE, Dudina V. The influence of stigma and discrimination on female sex workers’ access to HIV services in St. Petersburg, Russia. AIDS Behav. 2013;17(8):2597–603.CrossRefPubMed
38.
go back to reference Chakrapani V, Newman PA, Shunmugam M, Kurian AK, Dubrow R. Barriers to free antiretroviral treatment access for female sex workers in Chennai, India. AIDS Patient Care STDs. 2009;23(11):973–80.CrossRefPubMedPubMedCentral Chakrapani V, Newman PA, Shunmugam M, Kurian AK, Dubrow R. Barriers to free antiretroviral treatment access for female sex workers in Chennai, India. AIDS Patient Care STDs. 2009;23(11):973–80.CrossRefPubMedPubMedCentral
39.
go back to reference Mbonye M, Rutakumwa R, Weiss H, Seeley J. Alcohol consumption and high risk sexual behaviour among female sex workers in Uganda. Afr J AIDS Res. 2014;13(2):145–51.CrossRefPubMed Mbonye M, Rutakumwa R, Weiss H, Seeley J. Alcohol consumption and high risk sexual behaviour among female sex workers in Uganda. Afr J AIDS Res. 2014;13(2):145–51.CrossRefPubMed
40.
go back to reference Joint United Nations Programme on HIV/AIDS. UNAIDS guidance note on HIV and sex work. Geneva: Joint United Nations Programme on HIV/AIDS; 2012. Joint United Nations Programme on HIV/AIDS. UNAIDS guidance note on HIV and sex work. Geneva: Joint United Nations Programme on HIV/AIDS; 2012.
41.
go back to reference Cooke GS, Tanser FC, Bärnighausen TW, Newell M-L. Population uptake of antiretroviral treatment through primary care in rural South Africa. BMC Public Health. 2010;10(1):585.CrossRefPubMedPubMedCentral Cooke GS, Tanser FC, Bärnighausen TW, Newell M-L. Population uptake of antiretroviral treatment through primary care in rural South Africa. BMC Public Health. 2010;10(1):585.CrossRefPubMedPubMedCentral
42.
go back to reference Goldenberg SM, Montaner J, Duff P, et al. Structural barriers to antiretroviral therapy among sex workers living with HIV: findings of a longitudinal study in Vancouver, Canada. AIDS Behav. 2016;20(5):977.CrossRefPubMedPubMedCentral Goldenberg SM, Montaner J, Duff P, et al. Structural barriers to antiretroviral therapy among sex workers living with HIV: findings of a longitudinal study in Vancouver, Canada. AIDS Behav. 2016;20(5):977.CrossRefPubMedPubMedCentral
43.
go back to reference Mao L, Wit J, Kippax S, Prestage G, Holt M. Younger age, recent HIV diagnosis, no welfare support and no annual sexually transmissible infection screening are associated with nonuse of antiretroviral therapy among HIV-positive gay men in Australia. HIV Med. 2015;16(1):32–7.CrossRefPubMed Mao L, Wit J, Kippax S, Prestage G, Holt M. Younger age, recent HIV diagnosis, no welfare support and no annual sexually transmissible infection screening are associated with nonuse of antiretroviral therapy among HIV-positive gay men in Australia. HIV Med. 2015;16(1):32–7.CrossRefPubMed
44.
go back to reference Mbonye M, Nalukenge W, Nakamanya S, et al. Gender inequity in the lives of women involved in sex work in Kampala. Uganda. J Int AIDS Soc. 2012;15(Suppl 1):1–9.PubMed Mbonye M, Nalukenge W, Nakamanya S, et al. Gender inequity in the lives of women involved in sex work in Kampala. Uganda. J Int AIDS Soc. 2012;15(Suppl 1):1–9.PubMed
45.
go back to reference Moon T, Burlison J, Blevins M, et al. Enrolment and programmatic trends and predictors of antiretroviral therapy initiation from president’s emergency plan for AIDS Relief (PEPFAR)-supported public HIV care and treatment sites in rural Mozambique. Int J STD AIDS. 2011;22(11):621–7.CrossRefPubMed Moon T, Burlison J, Blevins M, et al. Enrolment and programmatic trends and predictors of antiretroviral therapy initiation from president’s emergency plan for AIDS Relief (PEPFAR)-supported public HIV care and treatment sites in rural Mozambique. Int J STD AIDS. 2011;22(11):621–7.CrossRefPubMed
46.
go back to reference Katz IT, Essien T, Marinda ET, et al. Antiretroviral refusal among newly diagnosed HIV-infected adults in Soweto, South Africa. AIDS. 2011;25(17):2177.CrossRefPubMedPubMedCentral Katz IT, Essien T, Marinda ET, et al. Antiretroviral refusal among newly diagnosed HIV-infected adults in Soweto, South Africa. AIDS. 2011;25(17):2177.CrossRefPubMedPubMedCentral
47.
go back to reference Lahuerta M, Lima J, Nuwagaba-Biribonwoha H, et al. Factors associated with late antiretroviral therapy initiation among adults in Mozambique. PLoS ONE. 2012;7(5):e37125.CrossRefPubMedPubMedCentral Lahuerta M, Lima J, Nuwagaba-Biribonwoha H, et al. Factors associated with late antiretroviral therapy initiation among adults in Mozambique. PLoS ONE. 2012;7(5):e37125.CrossRefPubMedPubMedCentral
48.
go back to reference Alvarez-Uria G, Pakam R, Midde M, Naik PK. Predictors of delayed antiretroviral therapy initiation, mortality, and loss to followup in HIV infected patients eligible for HIV treatment: data from an HIV cohort study in India. Biomed Res Int. 2013;2013:849042.PubMedPubMedCentral Alvarez-Uria G, Pakam R, Midde M, Naik PK. Predictors of delayed antiretroviral therapy initiation, mortality, and loss to followup in HIV infected patients eligible for HIV treatment: data from an HIV cohort study in India. Biomed Res Int. 2013;2013:849042.PubMedPubMedCentral
49.
go back to reference Sahoo DM. An analysis of widowhood in India: A global perspective. International Journal of Multidisciplinary and Current Research. 2014;2. Sahoo DM. An analysis of widowhood in India: A global perspective. International Journal of Multidisciplinary and Current Research. 2014;2.
50.
go back to reference Widows for peace through democracy. Dossier on widowhood: issues of discrmination for the attention of CEDAW. 2016. Widows for peace through democracy. Dossier on widowhood: issues of discrmination for the attention of CEDAW. 2016.
51.
go back to reference Brownridge DA, Hiebert-Murphy D, Ristock J, et al. Violence against separated, divorced, and married women in Canada, 2004. J Divorce Remarriage. 2008;49(3–4):308–29.CrossRef Brownridge DA, Hiebert-Murphy D, Ristock J, et al. Violence against separated, divorced, and married women in Canada, 2004. J Divorce Remarriage. 2008;49(3–4):308–29.CrossRef
52.
go back to reference Fleury RE, Sullivan CM, Bybee DI. When ending the relationship does not end the violence women’s experiences of violence by former partners. Violence Against Women. 2000;6(12):1363–83.CrossRef Fleury RE, Sullivan CM, Bybee DI. When ending the relationship does not end the violence women’s experiences of violence by former partners. Violence Against Women. 2000;6(12):1363–83.CrossRef
53.
go back to reference Teasdale CA, Wang C, Francois U, et al. Time to initiation of antiretroviral therapy among patients who are ART eligible in Rwanda: improvement over time. J Acquir Immune Defic Syndr. 2015;68(3):314.CrossRefPubMedPubMedCentral Teasdale CA, Wang C, Francois U, et al. Time to initiation of antiretroviral therapy among patients who are ART eligible in Rwanda: improvement over time. J Acquir Immune Defic Syndr. 2015;68(3):314.CrossRefPubMedPubMedCentral
54.
go back to reference Wright ST, Law MG, Cooper DA, et al. Temporal trends of time to antiretroviral treatment initiation, interruption and modification: examination of patients diagnosed with advanced HIV in Australia. J Int AIDS Soc. 2015;18(1):19463.CrossRefPubMedPubMedCentral Wright ST, Law MG, Cooper DA, et al. Temporal trends of time to antiretroviral treatment initiation, interruption and modification: examination of patients diagnosed with advanced HIV in Australia. J Int AIDS Soc. 2015;18(1):19463.CrossRefPubMedPubMedCentral
Metadata
Title
‘Test and Treat’ Among Women at High Risk for HIV-infection in Kampala, Uganda: Antiretroviral Therapy Initiation and Associated Factors
Authors
Yunia Mayanja
Onesmus Kamacooko
Daniel Bagiire
Gertrude Namale
Pontiano Kaleebu
Janet Seeley
Publication date
01-03-2018
Publisher
Springer US
Published in
AIDS and Behavior / Issue 3/2018
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-017-1973-5

Other articles of this Issue 3/2018

AIDS and Behavior 3/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.